Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures

Affiliations

• ¹ Department of Dermatology, Polyclinique Courlancy, Reims-Bezannes, France.
• ² Dermatology and Clinical Immunology Unit, Antony Hospital, Antony, France.
• ³ Department of Dermatology, Hôpital d'Instruction des Armées Begin, Saint Mandé, France.
• ⁴ Department of Dermatology, CHU Amiens-Picardie, Amiens, France.
• ⁵ Department of Dermatology, CHU Saint Etienne, Saint Etienne, France.
• ⁶ Department of Dermatology, Centre Hospitalier René Dubos, Pontoise, France.
• ⁷ Department of Dermatology, Centre Hospitalier Bretagne Sud, Lorient, France.
• ⁸ Department of Dermatology, Centre Hospitalier Le Havre, Le Havre, France.
• ⁹ Cabinet Médical, Paris, France.
• ¹⁰ Centre de Dermatologie Stanislas, Clinique Pasteur, Nancy, France.
• ¹¹ Department of Dermatology, Hopital Saint Joseph, Marseille, France.
• ¹² Department of Dermatology, Hôpital Paris Saint Joseph, Paris, France.
• ¹³ Department of Dermatology, Centre Hospitalier Régional Metz-Thionville, Thionville, France.
• ¹⁴ Centre de Santé Sabouraud, Hôpital Saint-Louis, Paris, France.
• ¹⁵ Cabinet Médical, Saint-Maur-des-Fossés, France.
• ¹⁶ Department of Dermatology, Centre Hospitalier Emile Roux, Le Puy-en-Velay, France.
• ¹⁷ Department of Dermatology, Centre Hospitalier d'Orléans, Orléans, France.
• ¹⁸ Cabinet Médical, Beauvais, France.
• ¹⁹ Department of Dermatology, CHI Poissy Saint Germain, Saint-Germain-en-Laye, France.